Navigation Links
Coronary Disease Might Toughen Up Heart
Date:10/1/2007

Mice with the ailment suffered less cardiac damage after injury, study finds

MONDAY, Oct. 1 (HealthDay News) -- Coronary artery disease may actually precondition the heart and make it more resistant to damage than hearts unaffected by the illness, a British study in mice suggests.

Researchers at the University of Bristol and the Bristol Heart Institute used mice that were genetically modified to be prone to fatty build-up in the coronary arteries. One group of these mice was fed a high-fat diet typical of Western nations, while the other group of mice was fed a normal rodent diet. The mice fed a high-fat diet developed coronary artery disease, while those fed the rodent diet did not.

The researchers then stopped and restarted the rodents' hearts -- mimicking the conditions used in heart bypass surgery.

They found that the hearts of the mice with coronary artery disease were less likely to be harmed than the hearts of healthy mice.

This suggests that coronary artery disease "preconditioned" the hearts -- they'd developed an innate protection against further damage, said the authors of the study, which is published in the October issue of the journal Critical Care Medicine.

The researchers noted that there's a common belief that in certain patients who survive a heart attack, the heart may have been naturally preconditioned against further damage.

This is something that surgeons and cardiologists may be able to exploit in order to protect the heart when treating people with coronary disease, suggested the team members, who are continuing their investigation into this internal heart protection mechanism.

More information

The American Academy of Family Physicians has more about coronary artery disease.



-- Robert Preidt



SOURCE: University of Bristol, news release, Sept, 30, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Coronary stent leads to complications
3. Coronary heart disease bids Adieu
4. Older Men Surviving Coronary Bypasses
5. The Benefits of abciximab with clopidogrel for percutaneous coronary intervention Questioned
6. The Link Between Oxidized Phospholipids And Coronary Artery Disease
7. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
8. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
9. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
10. Effectiveness Of Drug-Releasing Coronary Stents
11. Children Are At The Risk Of Inheriting Coronary Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... FL (PRWEB) , ... April 26, 2017 , ... ... and human performance, is proud to announce that it has received 510(k) clearance ... technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring ... birth defects research related to Zika virus during pregnancy, as well as other ... this important science. , The Teratology Society is an international ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology: